Organogenesis Holdings
ORGO
143 hedge funds and large institutions have $830M invested in Organogenesis Holdings in 2021 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 55 increasing their positions, 19 reducing their positions, and 19 closing their positions.
221% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 19
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
189% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 19
83% more capital invested
Capital invested by funds: $453M → $830M (+$377M)
42% more funds holding
Funds holding: 101 → 143 (+42)
19.54% more ownership
Funds ownership: 19.42% → 38.96% (+20%)
5% more call options, than puts
Call options by funds: $1.29M | Put options by funds: $1.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$88.2M |
| 2 |
DM
Deerfield Management
New York
|
+$78.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$72M |
| 4 |
Morgan Stanley
New York
|
+$33M |
| 5 |
NMIMC
Northwestern Mutual Investment Management Company
Milwaukee,
Wisconsin
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$26.7M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$9.34M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.18M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.55M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.21M |
ORGO Hedge Fund Activity: Q2 2021 in Review
143 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2021, worth a combined $830M — up 83% from $453M a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new ORGO positions and 19 closed out — a net gain of 42 holders — while 55 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $88.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $26.7M sold.
- 143 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2021, up from 101 in Q1 2021.
- Funds reported $830M of Organogenesis Holdings stock for Q2 2021, up 83% quarter-over-quarter.
- 61 funds opened new Organogenesis Holdings positions in Q2 2021 and 19 closed out, a net change of +42 holders.
- The largest Organogenesis Holdings buyer in Q2 2021 was BlackRock, an estimated $88.2M added.
- The largest Organogenesis Holdings seller in Q2 2021 was Avidity Partners Management, an estimated $26.7M sold.
Based on aggregated 13F filings for Q2 2021.